To further investigate the clinicopathological and prognostic significance of p62 levels in PTC patients, the p62 expression level was dichotomized into two groups, positive and negative, and we found that the expression of p62 was correlated with tumor size (p=0.0066) (Table 1). This evidence concerns the gene SQSTM1 and neoplasm.